查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球呼吸分析仪和药物检测设备市场
市场调查报告书
商品编码
1176572

2023-2030 年全球呼吸分析仪和药物检测设备市场

Global Breathalyzer and Drug Testing Equipment Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内（2023 年至 2030 年），呼吸分析仪和药物检测设备市场规模预计将以 16.8% 的复合年增长率增长。

酒精测试设备可为警察、工业和个人用途提供快速、可靠且卫生的预测试。 呼吸分析仪还具有数据存储功能，可快速访问过去的测试结果。 酒精测试使用诊断设备来估计一个人的血液酒精浓度 (BAC)。 通过向设备呼气，一个人可以确定他们是否超过了驾驶的法定限制。 需要血液、唾液、尿液或呼吸样本来确定一个人体内的酒精或乙醇含量。

市场动态

全球呼吸分析仪和药物检测设备市场受到技术进步的推动。 呼气分析仪和药物检测设备的日益普及、酒后驾车和吸毒成瘾事件的增加以及严格的政府法规和法律旨在减少在药物和酒精的影响下驾驶时发生的事故，推动了市场的发展。我来了。

在药物和酒精影响下发生的驾驶事故增加促进了市场增长

减少在药物和酒精影响下驾驶时发生事故的严格政府法规和法律将在预测期内推动市场发展。 根据世界卫生组织 2022 年报告，道路交通伤害是一个重大的公共卫生问题，也是全球死亡和受伤的主要原因。 每年约有 130 万人死于道路交通事故，数百万人受伤或致残，其中大部分发生在低收入和中等收入国家。 道路交通伤害不仅给个人、家庭和社区带来巨大的社会成本，而且给卫生服务和经济带来沉重负担。

酒精在许多社会中都具有文化和社会作用。 然而，我们在日常生活中的许多情况下都会经历酒精的有害影响。 大量文献表明，酒后驾车会显着增加事故的风险和严重程度，导致死亡和重伤。

世界卫生组织在其最新报告中估计，全世界 5% 至 35% 的道路死亡与酒精有关。 在大多数高收入国家，约 20% 的死亡驱动因素是血液酒精浓度超过法定限值。 低收入和中等收入国家的研究发现，33% 和 69% 的死亡事故司机以及 8% 和 29% 的非死亡事故司机在事故发生前饮酒。 在药物和酒精的影响下事故的增加以及政府法规的收紧正在推动全球市场。

一些呼吸分析仪给出不准确和错误的结果，阻碍了市场增长

但是，某些呼吸分析仪存在校准不当、化学溶液不当、改装不当、编程不当、方法不当、电子干扰、某些健康状况以及接触化学品等问题。有些可能会给出不准确和错误的结果，例如接触到 这些因素阻碍了市场的增长。

COVID-19 影响分析

COVID-19 的出现对全球呼吸分析仪和药物测试设备市场产生了积极影响。 根据 2021 年发表在《灾难医学与公共卫生防备》上的一篇文章，2019 年冠状病毒病大流行提供了一种准确、快速、简便的方法来应对社区爆发和评估疾病的传播。需要一种诊断工具可以管理。 呼吸分析技术中包含的人工智能已被证明具有通过分析呼吸中的挥发性有机化合物来诊断癌症和肺部疾病等各种疾病的潜力。 因此，我们认为它适用于在大规模公共卫生行动中诊断 COVID-19，因为它快速、易于使用且无创。

2022 年 4 月，美国食品和药物管理局发布了第一个 COVID-19 诊断测试的紧急使用授权，以检测呼吸样本中与 SARS-CoV-2 感染相关的化学物质。 可以在收集和测试患者标本的环境（例如诊所、医院和移动测试站点）中使用随身携带包大小的设备进行测试。

使用气相色谱-质谱 (GC-MS) 分析 COVID-19，以分离和鑑定呼出气中与 SARS-CoV-2 感染相关的化学物质和五种挥发性有机化合物的混合物。(VOC)，InspectIR COVID-19 呼气测醉器检测 SARS-CoV-2 的 VOC 标记物，产生假设的（未经证实的）阳性测试结果，需要通过分子测试进行确认。

内容

第 1 章市场研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 事故数量增加
      • 增加教育活动
    • 约束因素
      • 诊断不准确
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品类型

  • 氧化物半导体呼气分析仪
  • 燃料电池呼气分析仪
  • 分光光度呼吸分析仪

第八章应用

  • 酒精检测
  • 药物检测
  • 支气管哮喘检测
  • 结核病测试
  • 法医检查
  • 其他

第 9 章最终用户

  • 联邦机构
  • 医院
  • 康復中心
  • 私人公司
  • 其他

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 按类型划分的基准

第12章公司简介

  • C4 Development
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Cannabix Technologies Inc.
  • Intoxalock
  • Hound Labs
  • BACtrack
  • Lion Laboratories Limited
  • Intoximeters, Inc.
  • Lifeloc Technologies, Inc.
  • Lifesafer
  • Ekips Technologies

第13章 DataM

简介目录
Product Code: DMCD1129

Market Overview

Breathalyzer And Drug Testing Equipment Market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 16.8% during the forecast period (2023-2030).

Alcohol screening devices perform pretests in police, industrial and personal applications fast, reliable and hygienically. The breathalyzers also provide data storage for quick access to past test results. A breathalyzer test uses a diagnostic device to estimate a person's blood alcohol content (BAC). By blowing into the device, a person can determine whether they are over the legal limit to drive. Measuring the amount of alcohol, or ethanol, in a person's system requires a blood, saliva, urine, or breath sample.

Market Dynamics

Technological advancements drive the global breathalyzer and drug testing equipment market. The growing adoption of breathalyzers and drug testing equipment, the increasing number of drunk and drive cases and drug addiction and stringent government regulations and laws to reduce driving incidences under the influence of drugs and alcohol boosts the market.

Rising driving incidences under the influence of drugs and alcohol drives market growth

The stringent government regulations and laws to reduce driving incidences under the influence of drugs and alcohol drive the market in the forecast period. As per the World Health Organization Report 2022, road traffic injuries are a major public health problem and a foremost cause of death and injury worldwide. Every year around 1.3 million people die, and millions more are injured or disabled due to road crashes, mostly in low- and middle-income countries. As well as creating enormous social costs for individuals, families and communities, road traffic injuries heavily burden health services and economies.

Alcohol plays a cultural and social role in many societies. However, the harmful effects of alcohol experienced in many aspects of daily life are undeniable. An extensive body of literature identifies that driving after drinking alcohol significantly raises the risk of a crash and the severity of that crash, resulting in deaths and serious injuries.

In its latest reports, the WHO estimates that between 5% and 35% of global road deaths are alcohol-related. In most high-income countries, about 20% of fatally injured drivers have blood alcohol concentration levels above the legal limit. Studies in low- and middle-income countries have shown that 33% and 69% of fatally injured drivers and 8% and 29% of non-fatally injured drivers had consumed alcohol before their crashes. The rising incidences under the influence of drugs and alcohol and rising government regulations drive the market worldwide.

The inaccurate and wrong results provided by some breathalyzers will hamper the growth of the market

However, inaccurate and wrong results are provided by some breathalyzers due to improper calibration, incorrect chemical solutions, inappropriate modifications, faulty programming, improper methodology, electronic interference, certain health conditions, and exposure to chemicals. These factors are hampering the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 positively impacted the global breathalyzer and drug testing equipment market. According to the article published in Disaster Medicine and Public Health Preparedness in 2021, due to the coronavirus disease 2019 pandemic, there is a demand for accurate, rapid, and easy-to-administer diagnostic tools to support communities address local outbreaks and assess the spread of disease. Artificial intelligence within breath analysis techniques has been shown to potentially diagnose various diseases, such as cancer and lung disease, by analyzing volatile organic compounds in exhaled breath. This, combined with their rapid, easy-to-use, and noninvasive nature, makes them a suitable candidate for use in diagnosing COVID-19 in large-scale public health operations.

In April 2022, the U.S. Food and Drug Administration issued an emergency use authorization for the first COVID-19 diagnostic test that detects chemical compounds in breath samples related to a SARS-CoV-2 infection. The test can be conducted in environments where the patient specimen is collected and examined, such as doctor's offices, hospitals and mobile testing sites, utilizing an instrument about the carry-on luggage size.

The InspectIR COVID-19 Breathalyzer employs gas chromatography gas mass-spectrometry (GC-MS) to isolate and identify chemical mixtures and quickly detect five Volatile Organic Compounds (VOC) associated with SARS-CoV-2 infection in an exhaled breath when the InspectIR COVID-19 Breathalyzer detects VOC markers of SARS-CoV-2, a hypothetical (unconfirmed) positive test result is produced and should be confirmed with a molecular test.

Segment Analysis

The alcohol detection segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The alcohol detection segment accounts for the largest market share. Imagine the loss of lives caused due to people driving under the influence of alcohol. Through our alcohol detection device, police officers can instantly figure out people driving under the influence of alcohol and stop them, reducing drunk driving scenarios.

Manufacturers are providing the products in the market. For instance, Lifeloc Technologies, Inc. is a trusted U.S. manufacturer of precise, reliable And easy-to-use portable breath alcohol testing instruments (breathalyzers). Lifeloc's L Series of portable breath alcohol testers or "breathalyzers" are state-of-the-art and the most powerful, simple to use and advanced product on the market.

Also, in October 2022, Cannabix Technologies Inc., developer of breath testing devices for law enforcement and the workplace, reported that the Company had created a cutting-edge Contactless Alcohol Breathalyzer for workplaces and vehicles. Cannabix engineers have developed a suite of Contactless Alcohol Breathalyzer (CAB) offerings, including wall-mounted and in-vehicle (behind the steering column) versions.

Geographical Analysis

North America region holds the largest market share of the global Breathalyzer and Drug Testing Equipment market

North America dominates the breathalyzer and drug testing equipment market and is anticipated to show a parallel trend over the forecast period. An increasing number of accidents and awareness programs in the North American region drive the market.

According to the WHO report 2022, consuming alcohol can be an enjoyable activity for some people. However, many people may not realize the impact on body and can impair the ability to perform routine tasks. Drinking and driving is a dangerous combination. Evidence notes that in the U.S., it is responsible for roughly 28 deaths a day, costing the U.S. approximately $44 billion annually.

In the U.S., half a million people are injured and 17,000 killed every year in drunk driving-related traffic crashes. Almost 40% of all youth road fatalities are directly related to alcohol consumption.

Using breathalyzers can help reduce the number of motor vehicle accidents involving an alcohol-impaired driver. This device estimates the concentration of alcohol in the breath to decide whether a person has drunk too much alcohol to drive safely. All these factors are driving the market in the North American region.

Competitive Landscape

The breathalyzer and drug testing equipment market are a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are C4 Development, Cannabix Technologies Inc., Intoxalock, Hound Labs, BACtrack, Lion Laboratories Limited, Intoximeters, Inc., Lifeloc Technologies, Inc., Lifesafer, and Ekips Technologies, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the breathalyzer and drug testing equipment market globally.

For instance,

In October 2022, Cannabix Technologies Inc., developer of marijuana breathalyzer devices for law enforcement and the workplace, reports it will be partaking in a mid-October study date to test a supplemental version of its FAIMS technology for the detection of Delta 9-tetrahydrocannabinol and related analytes in human breath in a complete multi-analysis study of subjects under the effect of marijuana in the southern United States.

C4 Development

Overview:

C4 Development provides the most advanced tailor-made alcohol tester and ITS products to different countries. Alcovisor, a series of alcohol breath analyzers created and manufactured by the company. Alcovisor provides drivers with a testing machine to measure their alcohol degree before driving.

Product Portfolio:

JupiterX: This is android 5.1, built-in printer, GPS, 4G/WIFI Photo Capture, provide evidential records by auto-capturing while subject blowing, 100,000 test data stored in memory, 4.3" color touch screen. The mouthpiece can be automatically ejected, and a USB PC connection.

The global breathalyzer and drug testing equipment market report would provide access to approximately 55+ market data tables, 55+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing number of accidents
      • 4.1.1.2. Increase in the number of awareness programs
    • 4.1.2. Restraints:
      • 4.1.2.1. Inaccurate diagnosis
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Semiconductor Oxide Breathalyzers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Fuel Cell Breathalyzers
  • 7.4. Spectrophotometer Breathalyzers

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Alcohol Detection*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Drug Detection
  • 8.4. Asthma Detection
  • 8.5. Tuberculosis Detection
  • 8.6. Forensic Test
  • 8.7. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Federal Departments*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Hospitals
  • 9.4. Rehabilitation Centers
  • 9.5. Private Sectors
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Type Benchmarking

12. Company Profiles

  • 12.1. C4 Development*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Cannabix Technologies Inc.
  • 12.3. Intoxalock
  • 12.4. Hound Labs
  • 12.5. BACtrack
  • 12.6. Lion Laboratories Limited
  • 12.7. Intoximeters, Inc.
  • 12.8. Lifeloc Technologies, Inc.
  • 12.9. Lifesafer
  • 12.10. Ekips Technologies

LIST NOT EXHAUSTIVE

13. Global Breathalyzer and Drug Testing Equipment Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us